3D-PharmXchange

Foundation date

01/02/2010

Sector

#Professional Services and Consulting

Subsector

3D-PharmXchange is a consultancy firm providing integrated and immediate drug development and project management solutions to Biotech and Pharma companies. 3D-PharmXchange can take responsibility of interim management, complete development program design, organizational development, and consultancy projects. We make a difference by focusing on the creation of added value and reducing time to value for our clients. 3D-PharmXchange offers extensive strategic and operational experience in drug development and in project- and line management.

Upcoming events

Latest news

  • argenx reports topline results from ADVANCE-SC study of VYVGART Hytrulo in primary immune thrombocytopenia

    20 hours ago

  • Biocartis Holdings Inc.: Recapitalization completed and product portfolio expansion

    Wednesday November 22nd 2023

  • argenx announces European Commission approval of subcutaneous VYVGART® (efgartigimod alfa) for generalized myasthenia gravis

    Thursday November 16th 2023